Balduini CL, Noris P. Platelet count and aging. Haematologica. 2014;99(6):953-955.
Hermann W, Risch L, Grebhardt C, et al. Reference intervals for platelet counts in the elderly: results from the prospective SENIORLAB study. J Clin Med. 2020;9(9):2856.
Franchini M, Veneri D, Lippi G. Thrombocytopenia and infections. Expert Rev Hematol. 2017;10(1):99-106.
Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017;2017(1):385-399.
Arnold DM, Cuker A. Diagnostic approach to the adult with unexplained thrombocytopenia. UpToDate. Updated May 18, 2021. Accessed December 6, 2021. https://www.uptodate.com/contents/search
Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ. 2017;189(4):E153-E159.
Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med. 2010;362(7):600-613.
Uhl L, Assmann SF, Hamza TH, et al. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood. 2017;130(10):1247-1258.
Stasi R, Amadori S, Osborn J, et al. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med. 2006;3(3):e24.
Lee ACW. Pseudothrombocytopenia: what every clinician should know. Pediatr Neonatol. 2021;62(2):218-219.
Silczuk A, Habrat B. Alcohol-induced thrombocytopenia: current review. Alcohol. 2020;86:9-16.
Swain F, Bird R. How I approach new onset thrombocytopenia. Platelets. 2020;31(3):285-290.
Danese E, Montagnana M, Favaloro EJ, et al. Drug-induced thrombocytopenia. Semin Thromb Hemost. 2020;46(3):264-274.
Vayne C, Guéry EA, Rollin J, et al. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J Clin Med. 2020;9(7):2212.
Arnold DM, Kukaswadia S, Nazi I, et al. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013;11(1):169-176.
Temple RW, Burns B. Thrombocytopenia and neutropenia: a structured approach to evaluation. J Fam Pract. 2018;67(7):E1-E8.
Royer DJ, George JN, Terrell DR. Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol. 2010;84(5):421-429.
Sharma S, Rose H. Incidentally detected thrombocytopaenia in adults. Aust Fam Physician. 2014;43(10):700-704.
Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357(6):580-587.
University of Oklahoma Health Sciences Center. Drug-induced thrombocytopenia. Accessed July 22, 2021. https://ouhsc.edu/platelets/ditp.html
Kam T, Alexander M. Drug-induced immune thrombocytopenia. J Pharm Pract. 2014;27(5):430-439.
Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2012;2012:191-197.
Cooper N, Ghanima W. Immune thrombocytopenia. N Engl J Med. 2019;381(10):945-955.
- Arnold DM, Cuker A. Immune thrombocytopenia (ITP) in adults. UpToDate. Updated January 14, 2022. Accessed November 21, 2021. https://www.uptodate.com/contents/search
Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia [published correction appears on Blood Adv. 2020; 4(2): 252]. Blood Adv. 2019;3(23):3829-3866.
Matzdorff A, Meyer O, Ostermann H, et al. Immune thrombocytopenia - current diagnostics and therapy. Oncol Res Treat. 2018;41(suppl 5):1-30.
Mitchell O, Feldman DM, Diakow M, et al. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39-50.
Saab S, Brown RS. Management of thrombocytopenia in patients with chronic liver disease. Dig Dis Sci. 2019;64(10):2757-2768.
Nilles KM, Caldwell SH, Flamm SL. Thrombocytopenia and procedural prophylaxis in the era of thrombopoietin receptor agonists. Hepatol Commun. 2019;3(11):1423-1434.
Lovecchio F. Heparin-induced thrombocytopenia. Clin Toxicol (Phila). 2014;52(6):579-583.
Morgan RL, Ashoorion V, Cuker A, et al. Management of heparin-induced thrombocytopenia. Blood Adv. 2020;4(20):5184-5193.
Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT). Vasc Med. 2020;25(2):160-173.
Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360-3392.
Greinacher A. Clinical Practice. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252-261.
Crowther M. Management of heparin-induced thrombocytopenia. UpToDate. Updated August 3, 2021. Accessed December 13, 2021. https://www.uptodate.com/contents/search
McFarlane PA, Bitzan M, Broome C, et al. Making the correct diagnosis in thrombotic microangiopathy: a narrative review. Can J Kidney Health Dis. 2021;8 : 20543581211008707.
Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies. CMAJ. 2017;189(4):E153-E159.
Temple RW, Burns B. Thrombocytopenia and neutropenia: a structured approach to evaluation. J Fam Pract. 2018;67(7):E1-E8.
Bommer M, Wölfle-Guter M, Bohl S, et al. The differential diagnosis and treatment of thrombotic microangiopathies. Dtsch Arztebl Int. 2018;115(19):327-334.
Kantarcioglu B, Iqbal O, Walenga JM, et al. An update on the pathogenesis of COVID-19 and the reportedly rare thrombotic events following vaccination. Clin Appl Thromb Hemost. 2021;27 : 10760296211021498.
Perry RJ, Tamborska A, Singh B, et al.; CVT After Immunisation Against COVID-19 collaborators. Cerebral venous thrombosis after vaccination against COVID-19 in the UK. Lancet. 2021;398(10306):1147-1156.
Al-Nouri ZL, Reese JA, Terrell DR, et al. Drug-induced thrombotic microangiopathy. Blood. 2015;125(4):616-618.
Chatzikonstantinou T, Gavriilaki M, Anagnostopoulos A, et al. An update in drug-induced thrombotic microangiopathy. Front Med (Lausanne). 2020;7:212.
Pishko AM, Levine LD, Cines DB. Thrombocytopenia in pregnancy: diagnosis and approach to management. Blood Rev. 2020;40:100638.
Bergmann F, Rath W. The differential diagnosis of thrombocytopenia in pregnancy. Dtsch Arztebl Int. 2015;112(47):795-802.
American College of Obstetricians and Gynecologists. Thrombocytopenia in pregnancy. ACOG Practice Bulletin No. 207. Obstet Gynecol. 2019;133(3):e181-e193.
Reese JA, Peck JD, Deschamps DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379(1):32-43.
Subtil SFC, Mendes JMB, Areia ALFA, et al. Update on thrombocytopenia in pregnancy. Rev Bras Ginecol Obstet. 2020;42(12):834-840.
Kaufman RM, Djulbegovic B, Gernsheimer T, et al.; AABB. Platelet transfusion. Ann Intern Med. 2015;162(3):205-213.
Estcourt LJ, Stanworth SJ, Doree C, et al. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015(11):CD010983.
Solves Alcaina P. Platelet transfusion. J Blood Med. 2020;11:19-26.
Crighton GL, Estcourt LJ, Wood EM, et al. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015(9):CD010981.
Schiffer CA, Bohlke K, Delaney M, et al. Platelet transfusion for patients with cancer. J Clin Oncol. 2018;36(3):283-299.
Moore G, Durstine JL. ACSM's Exercise Management for Persons With Chronic Diseases and Disabilities. 4th ed. Human Kinetics; 2016.
Melo-Diaz LL. Thrombocytopenia and physical activity among older adults. Gerontol Geriatr Med. 2017;1(5):1-3.
Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician. 2012;85(6):612-622.